Johnson & Johnson has started 2025 better than I expected, even with the long-running talc saga. Find out why I remain ...

Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

Johnson & Johnson, one of the few remaining companies with a top credit rating, is no longer at risk of a downgrade, S&P Global Ratings said Friday. The maker of Tylenol as well as top-selling ...

Similarly, a Goldman Sachs report, comparing the gains by Hedge Fund VIP basket and the broader market, indicates that the top 50 stocks preferred by hedge funds have collectively returned 10% in 2025 ...

and Johnson & Johnson. Pharmaceutical Research and Manufacturers of America, the industry's trade group, has said it can take five to 10 years and $2 billion to launch a new U.S. production ...

it wasn't until 1959 – 73 years and two major acquisitions later – that J&J developed its significant presence in the pharmaceutical industry. In 1886, three brothers – Robert Wood Johnson ...

The U.S. pays the most for drugs in the world, often nearly three times that of other developed nations. "European price ...

The pharmaceutical industry has the largest lobbying ... It represents well-known drugmakers including Johnson & Johnson, Merck and Pfizer. The industry also wants Congress to restore a tax ...

and Johnson & Johnson. Pharmaceutical Research and Manufacturers of America, the industry's trade group, has said it can take five to 10 years and $2 billion to launch a new U.S. production facility ...

If you are someone who thinks investments should generate regular income, it is important to watch out for dividend stocks.